Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

1 registered trial, newest registry update first. Showing only trials linked to Pemvidutide.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
NCT06987513
PemvidutidePhase 2CompletedAltimmune, Inc.100Jul 30, 2026Jul 31, 2026

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.